2026³â 02¿ù 16ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

DIC Develops the MEGAFACE EFS Series of Environment-Friendly High-Performance PFAS-Free Surfactants

´º½ºÀÏÀÚ: 2023-08-04

TOKYO-- August 04, 2023 -- DIC Corporation (TOKYO:4631) today announced the development of the MEGAFACE™ EFS series of environment-friendly surfactants that deliver a performance rivaling that of conventional fluorosurfactants despite not containing perfluoroalkyl and polyfluoroalkyl substances (PFASs). These new products are suitable alternatives to fluorosurfactants for diverse applications, including displays, semiconductors, automobiles and coatings. The Company will promote the series in Japan, other East Asian markets, Europe and the United States, among others, targeting industries ranging from electronic materials to electric vehicles (EVs) and batteries, and aims to achieve annual sales of ¥5 billion by fiscal year 2030.

Fluorosurfactants, added in small amounts, lower the surface tension of liquids, improving emulsification and surface activity. They thus play a key role in detergents, coatings and industrial products, among others. However, concerns regarding latent environmental risks associated with PFASs have prompted debate over regulating these substances, particularly in Europe and the United States. This has driven up demand for the development of PFAS-free alternatives to fluorosurfactants.

DIC embarked on the development of a PFAS-free surfactant in a proactive response to rising global needs for sustainable alternatives to fluorosurfactants. Leveraging its proprietary technologies and environment-friendly raw materials, the Company succeeded in creating the MEGAFACE™ EFS series of products boasting surface activity equal to or better than that of conventional fluorosurfactants. While realizing PFAS-free surfactants that rival fluorosurfactants on the performance front has been seen as a difficult challenge, DIC has achieved this goal with the MEGAFACE™ EFS series of products with an ability to reduce surface tension as good or greater than that of fluorosurfactants, thereby ensuring excellent coating uniformity (leveling behavior).

Customers who usually use fluorosurfactants have rated the new series highly. Going forward, DIC will seek to build a market-leading position by offering these products globally as an alternative that contribute to the sustainability of industrial activity and the reduction of environmental risks.

In the DIC Vision 2030 long-term management plan, DIC sets forth a basic strategy of expanding its Functional Products business with a focus on sustainable products. The DIC Group will continue to leverage its extensive expertise and technical capabilities in synthetic resins to accelerate product development and sales and contribute to solving social issues.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Rimini Street Earns Industry Honors for AI Innovation, Client Focus, Technical Excellence and Business Impact
Lenovo Brings Real-Time Store Visibility and AI-Driven Support to Retail—Delivering Value on Day One
Blue Shift Report Highlights Systemic Vulnerabilities Caused by the Hidden Cost of AI
Australian Defence Force Secures Satellite Communications on SES IS-22
BlueMatrix and Perplexity Partner to Bring AI-Powered Discovery to Institutional Research
KIOXIA SSDs Achieve Compatibility with Microchip¡¯s Adaptec¢ç SmartRAID 4300 Series RAID Storage Accelerator
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

 

ACCELQ Crowned Leader and Customer Favorite in The Forrester Wave¢â fo...
Rigaku Launches ONYX 3200, a Metrology Instrument for Semiconductor Ma...
IntelliVIX Showcases ¡®K-AI¡¯ Prowess at CES 2026, Accelerating Global...
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J...
Interactive Brokers Redesigns IBKR GlobalTrader App for Simpler, Smart...
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of M...
Biocytogen, Acepodia Expand Collaboration on Option-Based Framework fo...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..